<p>Sticol® Volume Poly-L-Lactic Acid consists of a concentrated freeze-dried powder of pure poly-L-lactic acid at 210mg per vial. This substance, belonging to the family of synthetic polylactic acids, is characterized by its biocompatibility and biodegradability, recognized in surgery and aesthetic medicine for many years. No ingredients of animal or human origin are included in the product formulation, significantly reducing the risk of allergies or immune reactions.</p><p>Its formulation contains no additives, preservatives, or stabilizers. The pursuit of a simple composition aims to ensure purity, optimal tolerance, and a predictable response during injection. Before use, the powder is reconstituted in sterile isotonic sodium chloride (physiological saline) according to a precise volume defined by the manufacturer and adapted to the procedure intended by the professional.</p><ul><li>Unique active ingredient: Pure poly-L-lactic acid (PLLA) (210mg/vial)</li><li>Appearance: off-white, fine, freeze-dried powder</li><li>Without hyaluronic acid, without lidocaine, without additives</li><li>Free from any animal or human protein</li><li>To be mixed with sterile NaCl for injection</li><li>Sterile, non-pyrogenic, and apyrogenic product</li><li>Packaged in a sealed glass vial</li><li>Manufactured according to ISO quality standards and CE marking</li></ul><p>The reduced composition of Sticol® Volume allows for standardized management, limiting the risk of adverse effects related to other components. Compatibility with various reconstitution protocols ensures an application tailored to each patient and each volumetric indication of the face.</p><p>In summary, the purity and simplicity of the composition of Sticol® Volume make it a reliable and controlled device for advanced facial volumetry procedures.</p>
<p>The Sticol® Volume Poly-L-Lactic Acid contains only pure poly-L-lactic acid, without animal protein, additives, or preservatives, thus limiting the risk of allergies or hypersensitivity reactions.</p><p>However, the injection of PLLA may exceptionally lead to a local inflammatory reaction, nodules, or delayed granulomas, particularly in cases where injection techniques or post-procedure massage are not followed.</p><ul><li>Contraindicated in case of known allergy to polymers from the polylactic acid family</li><li>Do not use in pregnant or breastfeeding women</li><li>Not recommended for immunocompromised patients or those with active autoimmune diseases</li><li>Avoid in patients with active inflammation or infection at the injection site</li><li>As a precaution, report any hypersensitivity or unusual reaction to the responsible professional</li></ul><p>In case of a history of reactions to injectable devices, a prior tolerance test may be discussed with your patients. Adhering to medical indications and contraindications minimizes the risks of late allergic complications.</p>